Reckitt, GSK balance risk-reward in high-stakes Pfizer fight

LONDON (Reuters) - The leaders of GlaxoSmithKline and Reckitt Benckiser -- two of Britain's best-known but underperforming companies -- are in a high-stakes battle for a dose of Advil to ease their pain.

Reckitt, GSK balance risk-reward in high-stakes Pfizer fight
Read More


Bagikan Berita Ini